DRUG STUDY Drug Classification Mechanism of Action Unknown.

Appears toinhibit cellwallbiosynthesis byinterferingwit h lipidand DNAsynthesis Nursing Responsibilities >Activelygrowingt Contraindicated in >Peripheralneuro > Use cautiously ubercle bacilli patientswith pathy,fluiddiscol inelderlypatients > Prevention acutehepatic diseaseor oration,optic of tubercle bacilliin isoniazid-related neuritis,hepatitis > Peripheral thoseexposed liver damage neuropathy is more totuberculosisor common inpatients those withpositive who are slow skintest acetylators or who are resultswhose malnourished, chestx-rays alcoholic or diabetic andbacteriologicst udies >Monitor hepaticfunct areconsistentwith ionclosely for changes nonprogressivetuberc ulosis Indication Contraindication Side Effects

GENERIC NAME: Anti-infective HRZE (isoniazid+rifam picin+pyrazinami de+ethambutol) Brand name: Myrin

Generic: Fluimucil Brand Name: Acetylcysteine Classification : Antidotes Dose: 600mg/tab x5day more OD

Decrease viscosity of respiratory tract secretions and promote their removal by breaking disulfide bonds. In acetaminophen overdose, it protects the liver from injury by restoring glutathione levels or by acting as alternate substrate for acetaminophen metabolism.

Treatment of Hypersensitivity respiratory affections characterized by thick and viscous hypersecretions: acute and chronic bronchitis and its exacerbation, pulmonary emphysema, mucoviscidosis and bronchiectasis. Antidote in poisoning caused by paracetamol.

Nausea, vomiting and other G.I. symptoms, mild fever, hypotension, wheezing, dyspnea

Instruct the patient to follow directions exactly. Teach patient how to use and clean nebulizer. Inform patient that drug may have foul smell or taste. Tell patient to avoid driving or other hazardous activities

Generic Name: Levodropropizine Brand Name: Levopront

Anti-tussives

This medication is an antitussive, prescribed for cough.

Contraindicated in patients with severe liver impairment, excessive mucus discharge, and hypersensitivity.

Nausea, vomiting, heartburn, diarrhea, fatigue, weakness, drowsiness, dizziness, headache and palpitations.

* Caution should be exercised in patients with history of severe kidney insufficiency, any allergy, children, during pregnancy and breastfeeding. * It may cause dizziness or drowsiness, do not drive a car or operate machinery while taking this medication.

Generic Name: Ferrous Sulfate Tablets (FER-us SULL-fate) Brand Name: Examples include Feosol and Feratab

Vitamins & Minerals (Pre & Post Natal) / Anti-anemics

Ferrous sulfate facilitates O2 transport via hemoglobin. It is used as iron source as it replaces iron found in hemoglobin, myoglobin and other enzymes. Onset: Oral: 3-10 days. Absorption: Duodenum and upper jejunum: 10% absorption after oral admin in persons with normal serum iron stores; 20-30% absorption in those with inadequate iron stores. Excretion: Via urine, sweat, sloughing of the intestinal mucosa and menstruation.

Irondeficiency anemia

Patients receiving repeated blood transfusions; anemia not due to iron deficiency.

GI irritation, abdominal pain and cramps, nausea, vomiting, constipation, diarrhea, dark stool and discoloration of urine; heartburn.

Nursing Care Plan

ASSESSMENT
Subjective: Medyonahihirapanpoakonghumingaat inuubopoako, as verbalized by the patient Objective: > RR= 26 cycles per minute > Dyspnea > Use of accessory muscles when breathing. > Pale in appearance > Nasal flaring

DIAGNOSIS
Ineffective airway clearance related to the presence of secretions on the lung fields

PLANNING
Short Term Goal: After 1 hour of nursing intervention, the pt. will be able to cough up secretions effectively Long Term Goal: The patient will be able to verbalize effective airway clearance as characterized by: a. absence of cough b. lessenedsecretions

INTERVENTION
Independent: > Assessed airway patency

RATIONALE
-To monitor airway is always the first priority -To consider possible causes for ineffective cough -To ascertain state and note patients progress -To assess breathing pattern

EVALUATION
Short Term Goal: The patient is able to cough up secretions effectively. Goal met. Long Term Goal: Patient was uncooperative as manifested by her fatalistic attitude towards her condition. Goal partially met.

> Assessed cough for effectiveness and productivity > Auscultate breath sounds

> Observed for signs of respiratory distress(increased rate, use of accessory muscles) >Position patient to Semi-fowlers or sitting position

-To promote better lung expansion and improve air exchange -To reduce viscosity of mucus and easier

> Encourage to increase oral fluid intake

Recommendation: Take prescribed medications regularly

mobilization of secretions > Encourage deep breathing exercise -To reduce viscosity of mucus and easier mobilization of secretions -Prevents/reduces fatigue

> Encourage opportunities for rest; limit activities to level of respiratory resistance Dependent: > Administer Salbutamol NEB

-Increases the size of the tracheobronchial tree thus opening the airway passages -To examine and report changes in color and amount

> Provide information about the necessity of raising expectorations versus swallowing them